Impact of between-tissue differences on pan-cancer predictions of drug sensitivity.
Ontology highlight
ABSTRACT: Increased availability of drug response and genomics data for many tumor cell lines has accelerated the development of pan-cancer prediction models of drug response. However, it is unclear how much between-tissue differences in drug response and molecular characteristics may contribute to pan-cancer predictions. Also unknown is whether the performance of pan-cancer models could vary by cancer type. Here, we built a series of pan-cancer models using two datasets containing 346 and 504 cell lines, each with MEK inhibitor (MEKi) response and mRNA expression, point mutation, and copy number variation data, and found that, while the tissue-level drug responses are accurately predicted (between-tissue ρ = 0.88-0.98), only 5 of 10 cancer types showed successful within-tissue prediction performanc
SUBMITTER: Lloyd JP
PROVIDER: S-EPMC7906305 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA